Brighton Jones LLC’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.8M | Buy |
+89,649
| New | +$10.3M | 0.24% | 54 |
|
|
2025
Q4 | – | Sell |
-72,969
| Closed | -$6.12M | – | 616 |
|
|
2025
Q3 | $6.12M | Buy |
72,969
+20,086
| +38% | +$1.65M | 0.15% | 91 |
|
|
2025
Q2 | $4.19M | Buy |
52,883
+13,746
| +35% | +$1.09M | 0.11% | 110 |
|
|
2025
Q1 | $3.51M | Buy |
39,137
+859
| +2% | +$80.2K | 0.11% | 109 |
|
|
2024
Q4 | $3.81M | Buy |
38,278
+8,710
| +29% | +$898K | 0.11% | 106 |
|
|
2024
Q3 | $3.36M | Sell |
29,568
-2,174
| -7% | -$258K | 0.13% | 92 |
|
|
2024
Q2 | $3.93M | Buy |
31,742
+346
| +1% | +$44.6K | 0.13% | 89 |
|
|
2024
Q1 | $4.14M | Buy |
31,396
+200
| +0.6% | +$24.7K | 0.15% | 79 |
|
|
2023
Q4 | $3.4M | Buy |
31,196
+2,473
| +9% | +$257K | 0.14% | 87 |
|
|
2023
Q3 | $2.96M | Buy |
28,723
+819
| +3% | +$88.3K | 0.15% | 84 |
|
|
2023
Q2 | $3.22M | Buy |
27,904
+628
| +2% | +$71.3K | 0.16% | 84 |
|
|
2023
Q1 | $2.9M | Sell |
27,276
-302
| -1% | -$32.6K | 0.16% | 79 |
|
|
2022
Q4 | $3.06M | Buy |
27,578
+533
| +2% | +$54.5K | 0.18% | 72 |
|
|
2022
Q3 | $2.33M | Sell |
27,045
-765
| -3% | -$68.3K | 0.14% | 77 |
|
|
2022
Q2 | $2.54M | Buy |
27,810
+1,042
| +4% | +$92.4K | 0.15% | 79 |
|
|
2022
Q1 | $2.2M | Buy |
26,768
+360
| +1% | +$28.4K | 0.1% | 102 |
|
|
2021
Q4 | $2.02M | Sell |
26,408
-272
| -1% | -$21.7K | 0.1% | 101 |
|
|
2021
Q3 | $2M | Buy |
26,680
+1,624
| +6% | +$124K | 0.1% | 94 |
|
|
2021
Q2 | $1.95M | Sell |
25,056
-1,812
| -7% | -$135K | 0.1% | 92 |
|
|
2021
Q1 | $1.98M | Sell |
26,868
-3,087
| -10% | -$228K | 0.12% | 82 |
|
|
2020
Q4 | $2.34M | Buy |
29,955
+724
| +2% | +$55.4K | 0.14% | 67 |
|
|
2020
Q3 | $2.31M | Buy |
29,231
+3,916
| +15% | +$307K | 0.16% | 56 |
|
|
2020
Q2 | $1.87M | Sell |
25,315
-6,338
| -20% | -$477K | 0.15% | 59 |
|
|
2020
Q1 | $2.32M | Sell |
31,653
-1,210
| -4% | -$95.1K | 0.24% | 41 |
|
|
2019
Q4 | $2.85M | Sell |
32,863
-376
| -1% | -$30.9K | 0.31% | 42 |
|
|
2019
Q3 | $2.67M | Sell |
33,239
-232
| -0.7% | -$18.6K | 0.31% | 38 |
|
|
2019
Q2 | $2.68M | Sell |
33,471
-1,125
| -3% | -$86.1K | 0.31% | 41 |
|
|
2019
Q1 | $2.75M | Buy |
34,596
+1,432
| +4% | +$107K | 0.33% | 38 |
|
|
2018
Q4 | $2.42M | Buy |
33,164
+6,344
| +24% | +$448K | 0.35% | 36 |
|
|
2018
Q3 | $1.81M | Buy |
26,820
+8
| +0% | +$510 | 0.22% | 54 |
|
|
2018
Q2 | $1.55M | Buy |
26,812
+2,358
| +10% | +$133K | 0.2% | 63 |
|
|
2018
Q1 | $1.27M | Sell |
24,454
-2,853
| -10% | -$154K | 0.18% | 73 |
|
|
2017
Q4 | $1.47M | Sell |
27,307
-202
| -0.7% | -$11.2K | 0.18% | 69 |
|
|
2017
Q3 | $1.68M | Sell |
27,509
-688
| -2% | -$41.7K | 0.22% | 50 |
|
|
2017
Q2 | $1.72M | Buy |
+28,197
| New | +$1.72M | 0.24% | 46 |
|
|
2017
Q1 | – | Sell |
-4,697
| Closed | -$264K | – | 113 |
|
|
2016
Q4 | $264K | Sell |
4,697
-22,026
| -82% | -$1.29M | 0.1% | 78 |
|
|
2016
Q3 | $1.59M | Buy |
26,723
+414
| +2% | +$24.2K | 0.26% | 49 |
|
|
2016
Q2 | $1.45M | Sell |
26,309
-588
| -2% | -$31.3K | 0.26% | 50 |
|
|
2016
Q1 | $1.36M | Buy |
26,897
+12,288
| +84% | +$602K | 0.25% | 48 |
|
|
2015
Q4 | $736K | Buy |
14,609
+675
| +5% | +$34K | 0.14% | 87 |
|
|
2015
Q3 | $657K | Buy |
+13,934
| New | +$740K | 0.14% | 88 |
|
Other funds holding MRK
VCM
VPM
Brighton Jones LLC's MRK Position: Q1 2026 in Review
Brighton Jones LLC opened a new position in Merck (MRK) in Q1 2026: 89,649 shares worth $10.8M. The stake represents 0.24% of the portfolio and ranks #54 among its holdings. This is a return to the name: Brighton Jones LLC previously reported a position in MRK as recently as Q3 2025.
Brighton Jones LLC first reported a position in MRK in Q3 2015 and has held it in 41 quarters since. 3,788 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Brighton Jones LLC held 89,649 shares of Merck worth $10.8M as of Q1 2026.
- Merck was a new Brighton Jones LLC position in Q1 2026.
- Merck made up 0.24% of Brighton Jones LLC's portfolio in Q1 2026, its #54 holding.
- Brighton Jones LLC first reported a position in Merck in Q3 2015 and has held it in 41 quarters since.
- 3,788 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Brighton Jones LLC's 13F filing for Q1 2026, filed 28 Apr 2026.